LSTA Q3 2017 Earnings — Lisata Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

LSTALisata Therapeutics, Inc.

$44M

Q3 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$700

Operating Income

-$6M

Net Income

-$3M

EPS (Diluted)

$-5.66

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$1M

Free Cash Flow

-$1M

Stock-Based Comp.

$62,330

Balance Sheet

Total Assets

$68M

Total Liabilities

$15M

Stockholders' Equity

$53M

Cash & Equivalents

$15M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$9M	-100.0%
Gross Profit	-$700	$706,192	-100.1%
Operating Income	-$6M	-$6M	-7.0%
Net Income	-$3M	-$7M	+50.2%